BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 27052645)

  • 21. Patterns of initial recurrence and prognosis after sentinel lymph node biopsy and selective lymphadenectomy for melanoma.
    Wagner JD; Ranieri J; Evdokimow DZ; Logan T; Chuang TY; Johnson CS; Jung SH; Wenck S; Coleman JJ
    Plast Reconstr Surg; 2003 Aug; 112(2):486-97. PubMed ID: 12900606
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Final version of the American Joint Committee on Cancer staging system for cutaneous melanoma.
    Balch CM; Buzaid AC; Soong SJ; Atkins MB; Cascinelli N; Coit DG; Fleming ID; Gershenwald JE; Houghton A; Kirkwood JM; McMasters KM; Mihm MF; Morton DL; Reintgen DS; Ross MI; Sober A; Thompson JA; Thompson JF
    J Clin Oncol; 2001 Aug; 19(16):3635-48. PubMed ID: 11504745
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Prognosis associated with cutaneous melanoma metastases.
    Pan Y; Haydon AM; McLean CA; McDonald PB; Kelly JW
    Australas J Dermatol; 2015 Feb; 56(1):25-8. PubMed ID: 25688698
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Prognostic factors for melanoma.
    Wisco OJ; Sober AJ
    Dermatol Clin; 2012 Jul; 30(3):469-85. PubMed ID: 22800552
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Implications of the 2009 American Joint Committee on Cancer Melanoma Staging and Classification on dermatologists and their patients.
    Nading MA; Balch CM; Sober AJ
    Semin Cutan Med Surg; 2010 Sep; 29(3):142-7. PubMed ID: 21051007
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Estimates of stage-specific survival are altered by changes in the 2002 American Joint Committee on Cancer staging system for melanoma.
    Ben-Porat L; Panageas KS; Hanlon C; Patel A; Halpern A; Houghton AN; Coit D
    Cancer; 2006 Jan; 106(1):163-71. PubMed ID: 16331596
    [TBL] [Abstract][Full Text] [Related]  

  • 27. How staging of thin melanoma is changed after the introduction of TNM 7th edition: a population-based analysis.
    Caldarella A; Fancelli L; Manneschi G; Chiarugi A; Nardini P; Crocetti E
    J Cancer Res Clin Oncol; 2016 Jan; 142(1):73-6. PubMed ID: 26113451
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Melanoma staging and sentinel lymph node biopsy.
    Forsea AM
    Acta Dermatovenerol Croat; 2010; 18(4):279-88. PubMed ID: 21251448
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Improved stratification of pT1 melanoma according to the 8th American Joint Committee on Cancer staging edition criteria: A Dutch population-based study.
    Verver D; Louwman WJ; Koljenović S; Verhoef C; Grünhagen DJ; van Akkooi ACJ
    Eur J Cancer; 2018 Mar; 92():100-107. PubMed ID: 29217356
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Clinicopathological characteristics of cutaneous malignant melanoma in patients at a tertiary hospital in Macaronesia. Survival as a function of locoregional prognostic factors per the American Joint Committee on Cancer.
    Fernández-de-Misa Cabrera R; González Delgado B; Gambra Michel LE; Casale C; Lopez Figueroa A; Uña Gorospe J; Martínez Cedrés JC; Cabrera Suárez MA; Garrido Ríos S; Hernández Hernández N; Tébar Díaz A; Sánchez Barrios A; Allende Riera A; Perera Molinero A
    Int J Dermatol; 2018 Feb; 57(2):193-201. PubMed ID: 29247507
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Stage-specific prognostic biomarkers in melanoma.
    Cheng Y; Lu J; Chen G; Ardekani GS; Rotte A; Martinka M; Xu X; McElwee KJ; Zhang G; Zhou Y
    Oncotarget; 2015 Feb; 6(6):4180-9. PubMed ID: 25784655
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Clinical and prognostic factors for melanoma of the skin using SEER registries: collaborative stage data collection system, version 1 and version 2.
    Kosary CL; Altekruse SF; Ruhl J; Lee R; Dickie L
    Cancer; 2014 Dec; 120 Suppl 23():3807-14. PubMed ID: 25412392
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Defining the role of CD2 in disease progression and overall survival among patients with completely resected stage-II to -III cutaneous melanoma.
    Harcharik S; Bernardo S; Moskalenko M; Pan M; Sivendran M; Bell H; Hall LD; Castillo-Martín M; Fox K; Cordon-Cardo C; Chang R; Sivendran S; Phelps RG; Saenger Y
    J Am Acad Dermatol; 2014 Jun; 70(6):1036-44. PubMed ID: 24698703
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Is head and neck melanoma a distinct entity? A clinical registry-based comparative study in 5702 patients with melanoma.
    Hoersch B; Leiter U; Garbe C
    Br J Dermatol; 2006 Oct; 155(4):771-7. PubMed ID: 16965427
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Correlation between tumor cell proliferation and prognosis of primary cutaneous malignant melanoma in 127 patients].
    Wang Y; Xue WC; Si L; Cui CL; Lu AP; Cao DF; Guo J; Li ZW
    Zhonghua Bing Li Xue Za Zhi; 2013 Mar; 42(3):178-81. PubMed ID: 23769437
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Melanoma of the vulva and vagina: principles of staging and their relevance to management based on a clinicopathologic analysis of 85 cases.
    Seifried S; Haydu LE; Quinn MJ; Scolyer RA; Stretch JR; Thompson JF
    Ann Surg Oncol; 2015; 22(6):1959-66. PubMed ID: 25384702
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The prognostic effect of American Joint Committee on Cancer staging and genetic status in patients with choroidal and ciliary body melanoma.
    Bagger M; Andersen MT; Andersen KK; Heegaard S; Andersen MK; Kiilgaard JF
    Invest Ophthalmol Vis Sci; 2014 Dec; 56(1):438-44. PubMed ID: 25537201
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Prognostic Significance of Periadnexal Extension in Cutaneous Melanoma and its Implications for Pathologic Reporting and Staging.
    Dodds TJ; Lo S; Jackett L; Nieweg O; Thompson JF; Scolyer RA
    Am J Surg Pathol; 2018 Mar; 42(3):359-366. PubMed ID: 29240580
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Melanoma staging: where are we now?
    Piris A; Lobo AC; Duncan LM
    Dermatol Clin; 2012 Oct; 30(4):581-92, v. PubMed ID: 23021047
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Prognosis and determinants of outcome following locoregional or distant recurrence in patients with cutaneous melanoma.
    Francken AB; Accortt NA; Shaw HM; Wiener M; Soong SJ; Hoekstra HJ; Thompson JF
    Ann Surg Oncol; 2008 May; 15(5):1476-84. PubMed ID: 18196345
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.